A Public Health Approach to Hepatitis C Control in Low- and Middle-Income Countries

In light of new treatment regimens for hepatitis C, Amitabh Suthar and Anthony Harries outline a wider public health approach for tackling the disease.

• Publication year

  2015

• Venue

  PLoS Medicine

• Publication date

  2015-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1371/journal.pmed.1001795PMID 25757228PMCID 4355406
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hepatitis C Medicines: Technology and Market Landscape

  2015cited by this paper
• Global , regional , and national age – sex specifi c all-cause and cause-specifi c mortality for 240 causes of death , 1990 – 2013 : a systematic analysis for the Global Burden of Disease Study 2013

  2015cited by this paper
• Minimum target prices for production of direct-acting antivirals and associated diagnostics to combat hepatitis C virus

  2015cited by this paper
• Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

  2015cited by this paper
• Hepatitis C disease burden and strategies to manage the burden (Guest Editors Mark Thursz, Gregory Dore and John Ward)

  2014cited by this paper
• Treatment of hepatitis C: a systematic review.

  2014cited by this paper
• Global Distribution and Prevalence of Hepatitis C Virus Genotypes

  2014cited by this paper
• Antiviral treatment of hepatitis C

  2014cited by this paper
• Systematic Review of the Use of Dried Blood Spots for Monitoring HIV Viral Load and for Early Infant Diagnosis

  2014cited by this paper
• WHO guidance on the prevention of viral hepatitis B and C among people who inject drugs.

  2014cited by this paper
• Trends in HCV RNA testing among HCV antibody-positive persons in care, 2003-2010.

  2014cited by this paper
• Effect of preventive and curative interventions on hepatitis C virus transmission in Egypt (ANRS 1211): a modelling study.

  2014cited by this paper
• Risky behavior and correlates of HIV and Hepatitis C Virus infection among people who inject drugs in three cities in Afghanistan.

  2014cited by this paper
• Vertical Transmission of Hepatitis C Virus: Systematic Review and Meta-analysis

  2014cited by this paper
• Natural history of hepatitis C.

  2014cited by this paper
• Global epidemiology and genotype distribution of the hepatitis C virus infection.

  2014cited by this paper
• The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesis

  2013cited by this paper
• Blood Tests to Diagnose Fibrosis or Cirrhosis in Patients With Chronic Hepatitis C Virus Infection

  2013cited by this paper
• A Public Health Approach to Gun Violence

  2013cited by this paper
• Treatment of hepatitis C virus infection among people who are actively injecting drugs: a systematic review and meta-analysis.

  2013cited by this paper
• Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals

  2013cited by this paper
• High Coverage of ART Associated with Decline in Risk of HIV Acquisition in Rural KwaZulu-Natal, South Africa

  2013cited by this paper
• Combination Interventions to Prevent HCV Transmission Among People Who Inject Drugs: Modeling the Impact of Antiviral Treatment, Needle and Syringe Programs, and Opiate Substitution Therapy

  2013cited by this paper
• Therapy‐induced clearance of HCV core antigen from plasma predicts an end of treatment viral response

  2013cited by this paper
• Treatment as prevention and cure towards global eradication of hepatitis C virus.

  2013cited by this paper
• Current and future therapies for hepatitis C virus infection.

  2013cited by this paper
• Prevalence and estimation of hepatitis B and C infections in the WHO European Region: a review of data focusing on the countries outside the European Union and the European Free Trade Association

  2013cited by this paper
• Global epidemiology of hepatitis C virus infection: New estimates of age‐specific antibody to HCV seroprevalence

  2013cited by this paper
• Redefining global health-care delivery.

  2013cited by this paper
• Global Fund investments in harm reduction from 2002 to 2009.

  2012cited by this paper
• Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965.

  2012cited by this paper
• Percutaneous injuries before and after the Needlestick Safety and Prevention Act.

  2012cited by this paper
• Reshaping Global Health

  2012cited by this paper
• Incidence of acute hepatitis C virus infection among men who have sex with men with and without HIV infection: a systematic review

  2012cited by this paper
• Accuracy of Rapid and Point-of-Care Screening Tests for Hepatitis C

  2012cited by this paper
• Expanding access to treatment for hepatitis C in resource-limited settings: lessons from HIV/AIDS.

  2012cited by this paper
• Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis.

  2012cited by this paper
• Trends and projections of hepatitis C virus epidemiology in Latin America

  2011cited by this paper
• Towards an improved investment approach for an effective response to HIV/AIDS.

  2011cited by this paper
• Risk of Window Period Hepatitis‐C Infection in High Infectious Risk Donors: Systematic Review and Meta‐Analysis

  2011cited by this paper
• A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel

  2011cited by this paper
• A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt

  2011cited by this paper
• Comparison of a Newly Developed Automated and Quantitative Hepatitis C Virus (HCV) Core Antigen Test with the HCV RNA Assay for Clinical Usefulness in Confirming Anti-HCV Results

  2011cited by this paper
• Meta-analysis: increased mortality associated with hepatitis C in HIV-infected persons is unrelated to HIV disease progression.

  2009cited by this paper
• Dried blood spot for hepatitis C virus serology and molecular testing

  2009cited by this paper
• Laboratory challenges in the scaling up of HIV, TB, and malaria programs: The interaction of health and laboratory systems, clinical research, and service delivery.

  2009cited by this paper
• Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis

  2008cited by this paper
• Interim measures for meeting needs for health sector data: births, deaths, and causes of death.

  2007cited by this paper
• Antiviral treatment of hepatitis C

  2006cited by this paper
• Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy.

  2005cited by this paper
• Natural history of hepatitis C.

  2005cited by this paper
• The effect of tuberculosis control in China.

  2004cited by this paper
• Lack of Evidence of Sexual Transmission of Hepatitis C among Monogamous Couples: Results of a 10-Year Prospective Follow-Up Study

  2004cited by this paper
• Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa.

  2002cited by this paper
• Mandatory reporting of diseases and conditions by health care professionals and laboratories.

  1999cited by this paper
• Hepatitis C

  1998cited by this paper
• Natural history of hepatitis C

  1997cited by this paper
• Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group.

  1994cited by this paper
• Intraobserver and Interobserver Variations in Liver Biopsy Interpretation in Patients with Chronic Hepatitis C

  1994cited by this paper
• A FUTURES INSTITUTE

  1975cited by this paper
• The natural history of hepatitis.

  1969cited by this paper

• Stakeholders influence to reduce vitamin A deficiency in children aged 15 to 23 months in Iran: an analysis of stakeholders and networking

  2025cites this paper
• Identifying Gaps in the Treatment Guidelines for Hepatitis C in Peru to Meet International Standards: A Narrative Review

  2024cites this paper
• Current advances in Hepatitis C diagnostics

  2024cites this paper
• Asian Perspective on Hepatitis B Virus and Hepatitis C Virus Elimination

  2024cites this paper
• Budget impact analysis of two treatment approaches for hepatitis C in Malaysia through the use of voluntary and compulsory licensing options

  2023cites this paper
• An Assessment of National Strategic Action Plans for Viral Hepatitis Elimination, 2016-2021.

  2023cites this paper
• Hepatitis B vaccination in Iran: Historical policies and programs.

  2022cites this paper
• Comment on review article: Chronic hepatitis C virus infection cascade of care in pediatric patients

  2022cites this paper
• Hepatitis C Virus Infection in Persons Who Inject Drugs in the Middle East and North Africa: Intervention Strategies

  2021cites this paper
• The Ethics of Screening and Treating Persons with Hepatitis C: A Canadian Perspective

  2020cites this paper
• Accelerating the elimination of hepatitis C in Kuwait: An expert opinion

  2020cites this paper
• Effect of Vitamin C Supplementation on Serum Ascorbic Acid Level and Liver Function Profile in Healthy Individuals

  2020cites this paper
• A Pharmacology Perspective on Simultaneous Tuberculosis and Hepatitis C Treatment

  2019cites this paper
• A Path to Ending Hepatitis C in Ethiopia: A Phased Public Health Approach to Achieve Micro-Elimination.

  2019cites this paper
• Evaluation of a hepatitis C virus core antigen assay from venepuncture and dried blood spot collected samples: A cohort study

  2019cites this paper
• Hepatitis C virus-related policy-making in Iran: a stakeholder and social network analysis

  2019cites this paper
• Innovative strategies for the elimination of viral hepatitis at a national level: A country case series

  2019cites this paper
• Quasispecies dynamics in disease prevention and control

  2019influential citation
• Consensus recommendations on the diagnosis and treatment of hepatitis c virus infection in sub Saharan Africa

  2019cites this paper
• The challenges of hepatitis C management in Iran: A qualitative study with patients.

  2019cites this paper
• The hepatitis C infection in Iran: a policy analysis of agenda-setting using Kingdon’s multiple streams framework

  2019cites this paper
• Use of Ribavirin for Hepatitis C Treatment in the Modern Direct-acting Antiviral Era

  2018cites this paper
• Hepatitis C virus: Morphogenesis, infection and therapy

  2018cites this paper
• Implementation of a unique hepatitis C care continuum model in Rwanda.

  2018cites this paper
• Prevalence of hepatitis C virus among street children in Iran

  2018cites this paper
• HIV, HBV and HCV in people who inject drugs and are placed on methadone maintenance therapy, Yangon, Myanmar.

  2018cites this paper
• Prevalence of Vitamin D Deficiency in Hepatitis C Patients

  2018cites this paper
• The evaluation of point of care testing and dried blood spots to assess diagnostic accuracy of HCV infection as part of Sero-Molecular surveillance in people most-at-risk for hepatitis C virus

  2018cites this paper
• Enhanced molecular assays using strand-displacing polymerases and loop-mediated amplification (LAMP) with Bioluminescent Assay in Real Time (BART)

  2017cites this paper
• Pragmatic barriers for delay in access to HCV testing services: Perspective of People With Injecting Drugs and living with HIV

  2017cites this paper
• Clinical Characteristics Of Patients With Chronic Hepatitis C Infection At Initial Presentation To Tertiary Care In An Asian Middle-Income Country

  2017cites this paper
• Epidemiology and environmental aspects of marginal zone lymphomas.

  2017cites this paper
• A pilot study to expand treatment of chronic hepatitis C in resource-limited settings.

  2017cites this paper
• DOT-C: A cluster randomised feasibility trial evaluating directly observed anti-HCV therapy in a population receiving opioid substitute therapy from community pharmacy.

  2017cites this paper
• Prevalence of hepatitis B and C infection in persons living with HIV enrolled in care in Rwanda

  2017cites this paper
• Hepatitis C: A South African literature review and results from a burden of disease study among a cohort of drug-using men who have sex with men in Cape Town, South Africa.

  2017influential citation
• Hepatitis C virus pharmacogenomics in Latin American populations: implications in the era of direct-acting antivirals

  2017cites this paper
• RELATIONSHIP BETWEEN UVEITIS, DIFFERENT TYPES OF VIRAL HEPATITIS, AND LIVER CIRRHOSIS

  2016cites this paper
• Need of righteous attitudes towards eradication of hepatitis C virus infection in Latin America.

  2016cites this paper
• Guidelines for the screening, care and treatment of persons with chronic hepatitis C infection. Updated version, April 2016.

  2016influential citation
• Estimating the Impact of Expanding Treatment Coverage and Allocation Strategies for Chronic Hepatitis C in a Direct Antiviral Agent Era

  2016cites this paper
• Detection of Hepatitis C core antibody by dual-affinity yeast chimera and smartphone-based electrochemical sensing.

  2016cites this paper
• A 2015 roadmap for the management of hepatitis C virus infections in Asia

  2015cites this paper
• Hepatitis C: An Eastern Perspective.

  2015cites this paper
• Genetic Diversity Underlying the Envelope Glycoproteins of Hepatitis C Virus: Structural and Functional Consequences and the Implications for Vaccine Design

  2015cites this paper
• Quasispecies Dynamics in Disease Prevention and Control

  2015influential citation
• Incidence of hepatitis C in Brazil.

  2015cites this paper
• Knowledge and Practices of Barbers Regarding Hepatitis C Virus in El-Behira Governorate

  year unknowncites this paper